Home LiteratureArticle Details
PMID: 9469994 Published · ppublish English Case Reports Journal Article Research Support, U.S. Gov't, P.H.S.

Complete DiGeorge syndrome: persistence of profound immunodeficiency.

The Journal of pediatrics ·Vol. 132 ·No. 1 ·1998-01-00 ·Pages 15-21

Markert ML, Hummell DS, Rosenblatt HM, Schiff SE, Harville TO, Williams LW, Schiff RI, Buckley RH

Abstract

DiGeorge syndrome is characterized by developmental defects of the heart, parathyroid glands, and thymus. The objective of this study was to determine whether T-cell function spontaneously improves in patients with DiGeorge syndrome who have profoundly depressed T-cell proliferative responses to mitogens at presentation, regardless of the T-cell count. We conducted a retrospective chart review of eight patients with DiGeorge syndrome who had no proliferative responses to mitogens on presentation. Despite lack of responsiveness of the patients' peripheral blood lymphocytes to mitogens, T cells were occasionally detected, and the patients' cells often responded to IL-2 and in mixed lymphocyte reactions. Unresponsiveness to mitogens and clinical immunodeficiency persisted without immune-based therapy. One patient is alive and well after immunoreconstitution from thymic transplantation. The others either died early of complications of their disease such as gastroesophageal reflux with aspiration (2 patients) or infection (2 patients) or died after attempts at immunorestorative therapy with IL-2, thymus transplantation, or bone marrow transplantation (3 patients). Eight patients with DiGeorge syndrome who were first seen with no mitogen responsiveness did not improve spontaneously. We recommend HLA-identical bone marrow transplantation or thymic transplantation for these patients as soon as the diagnosis is confirmed.

MeSH Terms
Bone Marrow Transplantation CD3 Complex CD4 Antigens CD8 Antigens Child, Preschool DiGeorge Syndrome/diagnosis,immunology,therapy Fatal Outcome Flow Cytometry Graft vs Host Disease Humans Immunoglobulins/blood Infant Interleukin-2/therapeutic use Lymphocyte Activation Lymphocyte Count Retrospective Studies T-Lymphocytes/immunology Thymus Gland/transplantation
Chemicals
CD3 Complex CD4 Antigens CD8 Antigens Immunoglobulins Interleukin-2
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Markert M L
Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.
Hummell D S
Rosenblatt H M
Schiff S E
Harville T O
Williams L W
Schiff R I
Buckley R H
Article Info
Journal
The Journal of pediatrics
Abbr.
J Pediatr
ISSN
0022-3476
Published
1998-01-00
Pages
15-21
Language
English
Region
United States
NLM ID
0375410
Subset
IM
Grants
NCRR NIH HHS · M01-RR30 · United States
NIAID NIH HHS · U19-AI38550 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]